EpCAM expression is decreased upon EMT activation [14] and in some aggressive breast cancer cell lines, including normal-like cell lines (e.g., MDA-MB-231, SK-BR-7, BT549), which suggests that EpCAM-based CTCs detection may be insufficient [32,33]. The gene discussed is EPCAM; the disease is breast carcinoma.